文献速递慢性静脉疾病

孤立性症状性静脉曲张(C2期)主干消融联合或不联合静脉切除术的结局

Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease).
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-06-02

基于血管质量倡议静脉曲张注册数据库2015年1月至2019年3月的数据,纳入3375例症状性C2期静脉曲张患者,比较单纯主干消融与消融联合静脉切除术的结局。两组并发症发生率均低(8.6%),联合组感觉异常更常见(4.5% vs 1.3%,P<.001),但联合组VCSS改善和症状改善更显著。结论认为两种治疗均安全有效,支付方应继续覆盖。

要点

  • 症状性C2期静脉曲张患者中,单纯消融与消融联合静脉切除术的总体并发症发生率均低(8.6%)。
  • 联合组感觉异常发生率高于单纯消融组(4.5% vs 1.3%,P<.001)。
  • 联合组VCSS改善中位数5分优于单纯消融组的3分(P<.001)。

核心结论

  • 对于孤立性症状性静脉曲张(C2期),单纯消融与消融联合静脉切除术均安全有效,可改善患者报告结局和临床严重程度(VCSS)。

研究设计与样本

  • 基于血管质量倡议静脉曲张注册数据库2015年1月至2019年3月的数据,纳入3375例记录为症状性C2期静脉曲张接受主干腔内消融的患者。
  • 其中40.1%(1376例)接受单纯主干消融,59.9%(1999例)接受消融联合静脉切除术。
  • 采用t检验、χ2检验或非参数检验进行术前术后比较,并对有序结局变量进行多变量有序逻辑回归。

主要发现

  • 总体并发症发生率为8.6%,单纯消融组为8.4%,联合组为8.7%(P=.820)。
  • 最常见并发症为感觉异常,总体3.4%;联合组4.5%高于单纯消融组1.3%(P<.001)。
  • 87.4%的患者VCSS改善,中位改善4分(IQR 2-5);单纯消融组中位改善3分(IQR 1-5),联合组中位改善5分(IQR 3-5)(P<.001)。
  • 94.4%的患者总体症状改善,中位改善11分(最大30分);联合组中位改善12分(IQR 8-17)优于单纯消融组9分(IQR 5-13)(P<.001)。

临床怎么用

  • 对于症状性C2期静脉曲张,单纯主干消融与联合静脉切除术均可作为安全有效的治疗选择。
  • 联合静脉切除术可能带来更大的VCSS和症状改善,但需注意感觉异常风险较高。
  • 研究数据支持支付方继续覆盖上述介入治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many insurance payers are hesitating to cover interventional treatments in patients with isolated symptomatic varicose veins. In this study, we sought to determine the outcomes of patients with varicose veins who were treated with venous ablation alone or ablation plus phlebectomy using the Vascular Quality Initiative Varicose Vein Registry. METHODS: Using data from the Varicose Vein Registry between January 2015 and March 2019, we investigated immediate postoperative as well as long-term clinical and patient-reported outcomes among patients with documented symptomatic C2 disease undergoing truncal endovenous ablations alone and combined ablation and phlebectomy. Preprocedural and postprocedural comparisons were performed using t-test, χ2 test, or nonparametric tests when appropriate. Multivariable ordinal logistic regression was performed on ordinal outcome variables. RESULTS: Among 3375 patients with symptomatic C2 disease, 40.1% of patients (1376) underwent isolated truncal ablation and 59.9% (1999) underwent ablation and phlebectomy. Complications overall were low (8.6%) and varied between 8.4% and 8.7% in patients undergoing ablation alone and ablation plus phlebectomy, respectively (P = .820). The most common complication noted was paresthesia, 3.4% overall, which occurred more commonly after ablation and phlebectomy (4.5%) than after ablation alone (1.3%; P < .001). An improvement in Venous Clinical Severity Score (VCSS) was experienced by 87.4% of patients; median change in VCSS was 4 points (interquartile range [IQR], 2-5 points), with an improvement of 3 points among patients undergoing ablation alone (IQR, 1-5 points) and 5 points among patients undergoing ablation and phlebectomy (IQR, 3-5 points; P < .001). An improvement in overall symptoms was experienced by 94.4% of patients (median improvement, 11 points; (maximum, 30 points), with more significant decreases among patients undergoing ablation and phlebectomy (median, 12 points; IQR, 8-17 points) compared with ablation alone (median, 9 points; IQR, 5-13 points; P < .001). CONCLUSIONS: Among patients with isolated symptomatic varicose veins (C2 disease), ablation and ablation with phlebectomy are safe and effective in improving both patient-reported outcomes and clinical severity (VCSS). Given these data, payers should continue to cover these treatments.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Brown CS, Obi AT, Cronenwett JL, et al. Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease). J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32502731. doi:10.1016/j.jvsv.2020.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。